Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Frigerio

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|January 24, 2018
The Chemical Design and Synthesis of Linkers Used in Antibody Drug ConjugatesMark Frigerio, Andrew F Kyle
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2019
Bridged Cysteine ConjugationsMatthew Bird, Joao Nunes, Mark Frigerio
Organic Letters|February 14, 2003
New, abridged pathway to Masamune's "southern hemisphere" intermediate for the total synthesis of bryostatin 7Karl J Hale, Mark Frigerio, Soraya Manaviazar
Natural Product Reports|August 28, 2002
The chemistry and biology of the bryostatin antitumour macrolidesKarl J Hale, Marc G Hummersone, Soraya Manaviazar, et al.
Organic Letters|September 22, 2006
Enantioselective formal total synthesis of the antitumor macrolide bryostatin 7Soraya Manaviazar, Mark Frigerio, Gurpreet S Bhatia, et al.
Organic Letters|March 15, 2002
A biosynthetic proposal for ring formation in the antitumor agent halichomycin. Asymmetric synthesis of the AB-carbon backbone of halichomycinKarl J Hale, Paschalis Dimopoulos, Maxine L F Cheung, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 4, 2026
Bismuth BicyclesSaan Voss, Amin Sagar, Arnaud Tiberghien, et al.
Scientific Reports|October 14, 2021
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane markerMarta Poblocka, Akang Leonard Bassey, Victoria M Smith, et al.
Organic Letters|February 14, 2003
Synthesis of a simplified bryostatin C-ring analogue that binds to the CRD2 of human PKC-alpha and construction of a novel BC-analogue by an unusual Julia olefination processKarl J Hale, Mark Frigerio, Soraya Manaviazar, et al.
Mabs|June 4, 2019
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4Katherine Griffiths, Uli Binder, William McDowell, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|January 24, 2018
The Chemical Design and Synthesis of Linkers Used in Antibody Drug ConjugatesMark Frigerio, Andrew F Kyle
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2019
Bridged Cysteine ConjugationsMatthew Bird, Joao Nunes, Mark Frigerio
Organic Letters|February 14, 2003
New, abridged pathway to Masamune's "southern hemisphere" intermediate for the total synthesis of bryostatin 7Karl J Hale, Mark Frigerio, Soraya Manaviazar
Natural Product Reports|August 28, 2002
The chemistry and biology of the bryostatin antitumour macrolidesKarl J Hale, Marc G Hummersone, Soraya Manaviazar, et al.
Organic Letters|September 22, 2006
Enantioselective formal total synthesis of the antitumor macrolide bryostatin 7Soraya Manaviazar, Mark Frigerio, Gurpreet S Bhatia, et al.
Organic Letters|March 15, 2002
A biosynthetic proposal for ring formation in the antitumor agent halichomycin. Asymmetric synthesis of the AB-carbon backbone of halichomycinKarl J Hale, Paschalis Dimopoulos, Maxine L F Cheung, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 4, 2026
Bismuth BicyclesSaan Voss, Amin Sagar, Arnaud Tiberghien, et al.
Scientific Reports|October 14, 2021
Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane markerMarta Poblocka, Akang Leonard Bassey, Victoria M Smith, et al.
Organic Letters|February 14, 2003
Synthesis of a simplified bryostatin C-ring analogue that binds to the CRD2 of human PKC-alpha and construction of a novel BC-analogue by an unusual Julia olefination processKarl J Hale, Mark Frigerio, Soraya Manaviazar, et al.
Mabs|June 4, 2019
Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4Katherine Griffiths, Uli Binder, William McDowell, et al.
Pageof 2